Showing 901-910 of 1690 results for "".
Avoid Financial Gridlock When Partners Disagree: Three Ideas for Every Group Practice
https://practicalneurology.com/columns/practice-management/avoid-financial-gridlock-when-partners-disagree-three-ideas-for-every-group-practice/30460/In Epilepsy Care, Non-pharmacologic Research Takes Center Stage
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-epilepsy-care-non-pharmacologic-research-takes-center-stage/30602/Researchers say minimally invasive surgeries, alternative interventions, and new genetic findings are the top stories of 2014.An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?- Delve Deeper into Sleep Disordershttps://practicalneurology.com/diseases-diagnoses/sleep/PN0605SleepDisorders-pdf/31446/Comprehensive Overview of Sleep Disorders: Diagnostic and Clinical InsightsSleep disorders present significant diagnostic challenges due to overlapping symptoms such as excessive daytime sleepiness (EDS). Accurate diagnosis is crucial for effective treatment, necessitating a deep understanding of ea
Seeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBChronic Facial Weakness and Deafness
https://practicalneurology.com/diseases-diagnoses/stroke/chronic-facial-weakness-and-deafness/31104/A 66-year-old Indian man reported bilateral facial weakness that started when he was 15 to 20 years old and affected both upper and lower parts of the face. Two to three years later, he developed hoarseness and was found to have bilateral vocal cord paralysis, which required a tracheostomy several y- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31146/Celiac Disease and Its Neurological Implications: Essential Insights for NeurologistsCeliac disease (CD), an autoimmune disorder triggered by gluten ingestion in genetically predisposed individuals, is traditionally recognized for its gastrointestinal manifestations such as chronic diarrhea, weight
- Exploring the Connection Between Epilepsy and Religionhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0508Religion-pdf/31027/Epilepsy and Its Intersection with Religious Experiences: Historical and Clinical InsightsEpilepsy has long been intertwined with religious and supernatural beliefs, a relationship that has evolved significantly over millennia. Historically, civilizations such as the Greeks and Romans attributed sei
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31080/Differential Diagnosis and Management of Severe Orbital, Frontal, and Facial Pain SyndromesIn a recent case presented by Nahas et al., an 68-year-old male experienced a three-month history of recurrent, intense pain localized to the right eye, forehead, and face. Described as stabbing and lancinatin
- Managing Nocturnal Agitation in Dementia Patientshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1205nocturnalagitation-pdf/31367/Managing Nocturnal Agitation in Dementia Patients: Insights and StrategiesNocturnal agitation, commonly referred to as "sundowning," is a prevalent phenomenon in dementia patients, characterized by increased behavioral disturbances such as agitation, confusion, disorientation, and wandering during t